BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34387166)

  • 1. Zinc 1,2,4-triazolo[1,5-a]pyrimidine Complexes: Synthesis, Structural Characterization and their Effect Against Chagas Disease.
    Méndez-Arriaga JM; Rubio-Mirallas E; Quirós M; Sánchez-Moreno M
    Med Chem; 2022; 18(4):444-451. PubMed ID: 34387166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. First Example of Antiparasitic Activity Influenced by Thermochromism: Leishmanicidal Evaluation of 5,7-dimethyl-1,2,4-triazolo[1,5-a]pyrimidine Metal Complexes.
    Méndez-Arriaga JM; Oyarzabal I; Martín-Montes Á; García-Rodríguez J; Quirós M; Sánchez-Moreno M
    Med Chem; 2020; 16(3):422-430. PubMed ID: 30931864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro leishmanicidal and trypanocidal evaluation and magnetic properties of 7-amino-1,2,4-triazolo[1,5-a]pyrimidine Cu(II) complexes.
    Méndez-Arriaga JM; Oyarzabal I; Escolano G; Rodríguez-Diéguez A; Sánchez-Moreno M; Salas JM
    J Inorg Biochem; 2018 Mar; 180():26-32. PubMed ID: 29227923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmanicidal and Trypanocidal Activity of Metal Complexes with 1,2,4-Triazolo[1,5-a]pyrimidines: Insights on their Therapeutic Potential against Leishmaniasis and Chagas Disease.
    Salas JM; Caballero AB; Esteban-Parra GM; Méndez-Arriaga JM
    Curr Med Chem; 2017; 24(25):2796-2806. PubMed ID: 28521698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-diabetic and anti-parasitic properties of a family of luminescent zinc coordination compounds based on the 7-amino-5-methyl-1,2,4-triazolo[1,5-a]pyrimidine ligand.
    Esteban-Parra GM; Sebastián ES; Cepeda J; Sánchez-González C; Rivas-García L; Llopis J; Aranda P; Sánchez-Moreno M; Quirós M; Rodríguez-Diéguez A
    J Inorg Biochem; 2020 Nov; 212():111235. PubMed ID: 32920434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triazolopyrimidine compounds containing first-row transition metals and their activity against the neglected infectious Chagas disease and leishmaniasis.
    Caballero AB; Rodríguez-Diéguez A; Quirós M; Salas JM; Huertas Ó; Ramírez-Macías I; Olmo F; Marín C; Chaves-Lemaur G; Gutierrez-Sánchez R; Sánchez-Moreno M
    Eur J Med Chem; 2014 Oct; 85():526-34. PubMed ID: 25127147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into Structure and Biological Activity of Copper(II) and Zinc(II) Complexes with Triazolopyrimidine Ligands.
    Argăseală A; Maxim C; Badea M; Ioniță L; Chifiriuc MC; Rostas AM; Bacalum M; Răileanu M; Ruţă LL; Farcaşanu IC; Iorgulescu EE; Olar R
    Molecules; 2022 Jan; 27(3):. PubMed ID: 35164029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiparasitic activity against trypanosomatid diseases and novel metal complexes derived from the first time characterized 5-phenyl-1,2,4-triazolo[1,5-a]pyrimidi-7(4H)-one.
    Méndez-Arriaga JM; Esteban-Parra GM; Juárez MJ; Rodríguez-Diéguez A; Sánchez-Moreno M; Isac-García J; Salas JM
    J Inorg Biochem; 2017 Oct; 175():217-224. PubMed ID: 28780409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lanthanide complexes containing 5-methyl-1,2,4-triazolo[1,5-a] pyrimidin-7(4H)-one and their therapeutic potential to fight leishmaniasis and Chagas disease.
    Caballero AB; Rodríguez-Diéguez A; Salas JM; Sánchez-Moreno M; Marín C; Ramírez-Macías I; Santamaría-Díaz N; Gutiérrez-Sánchez R
    J Inorg Biochem; 2014 Sep; 138():39-46. PubMed ID: 24861807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo antiparasital activity against Trypanosoma cruzi of three novel 5-methyl-1,2,4-triazolo[1,5-a]pyrimidin-7(4H)-one-based complexes.
    Caballero AB; Marín C; Rodríguez-Diéguez A; Ramírez-Macías I; Barea E; Sánchez-Moreno M; Salas JM
    J Inorg Biochem; 2011 Jun; 105(6):770-6. PubMed ID: 21497152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, structure-activity relationship and trypanocidal activity of pyrazole-imidazoline and new pyrazole-tetrahydropyrimidine hybrids as promising chemotherapeutic agents for Chagas disease.
    Monteiro ME; Lechuga G; Lara LS; Souto BA; Viganó MG; Bourguignon SC; Calvet CM; Oliveira FOR; Alves CR; Souza-Silva F; Santos MS; Pereira MCS
    Eur J Med Chem; 2019 Nov; 182():111610. PubMed ID: 31434040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High antiparasitic activity of silver complexes of 5,7-dimethyl-1,2,4-triazolo[1,5 a]pyrimidine.
    Esteban-Parra GM; Méndez-Arriaga JM; Rodríguez-Diéguez A; Quirós M; Salas JM; Sánchez-Moreno M
    J Inorg Biochem; 2019 Dec; 201():110810. PubMed ID: 31493678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo trypanocidal evaluation of nickel complexes with an azapurine derivative against Trypanosoma cruzi.
    Maldonado CR; Marín C; Olmo F; Huertas O; Quirós M; Sánchez-Moreno M; Rosales MJ; Salas JM
    J Med Chem; 2010 Oct; 53(19):6964-72. PubMed ID: 20812723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroleptic oxidovanadium(IV) complexes of 2-hydroxynaphtylaldimine and polypyridyl ligands against Trypanosoma cruzi and prostate cancer cells.
    Scalese G; Mosquillo MF; Rostán S; Castiglioni J; Alho I; Pérez L; Correia I; Marques F; Costa Pessoa J; Gambino D
    J Inorg Biochem; 2017 Oct; 175():154-166. PubMed ID: 28755573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repositioning of leishmanicidal [1,2,3]Triazolo[1,5-a]pyridinium salts for Chagas disease treatment: Trypanosoma cruzi cell death involving mitochondrial membrane depolarisation and Fe-SOD inhibition.
    Martín-Escolano R; Martín-Escolano J; Ballesteros-Garrido R; Cirauqui N; Abarca B; Rosales MJ; Sánchez-Moreno M; Ballesteros R; Marín C
    Parasitol Res; 2020 Sep; 119(9):2943-2954. PubMed ID: 32607710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural design, synthesis and pharmacological evaluation of thiazoles against Trypanosoma cruzi.
    de Oliveira Filho GB; Cardoso MVO; Espíndola JWP; Oliveira E Silva DA; Ferreira RS; Coelho PL; Anjos PSD; Santos ES; Meira CS; Moreira DRM; Soares MBP; Leite ACL
    Eur J Med Chem; 2017 Dec; 141():346-361. PubMed ID: 29031078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of new dinuclear Fe(III) coordination compounds with
    Moreira FF; Portes JA; Barros Azeredo NF; Fernandes C; Horn A; Santiago CP; Segat BB; Caramori GF; Madureira LMP; Candela DRS; Marques MM; Lamounier Camargos Resende JA; de Souza W; DaMatta RA; Seabra SH
    Dalton Trans; 2021 Sep; 50(35):12242-12264. PubMed ID: 34519725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising fluconazole based zinc(II) and copper(II) coordination polymers against Chagas disease.
    de Azevedo-França JA; Barrias E; Franco CHJ; Villarreal W; Vieira EG; Ferreira AMDC; de Souza W; Navarro M
    J Inorg Biochem; 2022 Aug; 233():111834. PubMed ID: 35500350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
    Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
    Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Fluorination on the Structure and Anti-
    Salsi F; Bulhões Portapilla G; Simon S; Roca Jungfer M; Hagenbach A; de Albuquerque S; Abram U
    Inorg Chem; 2019 Aug; 58(15):10129-10138. PubMed ID: 31310108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.